Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cypherpunk Technologies Inc

CYPH ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: BUY

Last Close

$0.64

▼ -0.62%

Market Cap $69.40M · Vol 72.71K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$69.40M

Micro Cap

Div Yield

N/A

EPS Growth

-828.57%

YoY

RSI (14)

52.48

Momentum

Beta

0.07

vs Market

52W High

$3.69

82.55% below

52W Low

$0.25

155.56% above

Volume

72.71K

Avg 196.07K

P/B

0.63

Price-to-book

ROE

N/A

Return on equity

Free Float

92.73%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Cypherpunk Technologies Inc (CYPH) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CYPH pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.48%

-12.00%

-46.33%

-9.28%

YTD

-44.48%

+164.37%

-74.65%

-96.17%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$4.82M
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	9.49% · 5.13%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	0.16
P/S	N/A
P/B	0.63
P/FCF	N/A
EPS Growth	-828.57%
Outstanding Shares	107.76M

Technical Indicators

50-Day SMA	$0.68
200-Day SMA	$0.92
RSI (14)	52.48
Beta	0.07
52-Week High	$3.69
52-Week Low	$0.25

Volume Today	72.71K
Avg Daily Volume (30D)	196.07K
Relative Volume	0.37x
Volatility (10D)	77.64
Volatility (30D)	72.39
Free Float	92.73%

Analyst Consensus

BUY

Current Price $0.64

Mean Target $0.90

52W Low$0.25 52W High$3.69

Current

Target

$0.25 $3.69

Current Analyst target

+39.75% upside potential · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00DQ929Z3

ISINUS52187K2006

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateNov 12, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.